These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 366978

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Minimum steriod requirements in renal transplant patients monitored by urinary fibrin degradation products and complement.
    Anderton JL, Fananapazir L, Eccleston M.
    Proc Eur Dial Transplant Assoc; 1977; 14():342-50. PubMed ID: 341136
    [Abstract] [Full Text] [Related]

  • 23. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM, Ofstad J, Thunold S, Willassen Y.
    Tidsskr Nor Laegeforen; 1976 Jan 20; 96(2):91-3. PubMed ID: 766292
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN, Kozlovskaia LV, Rameeva AS, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2007 Jan 20; 79(6):10-5. PubMed ID: 17684960
    [Abstract] [Full Text] [Related]

  • 25. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S, Ideura T, Ida T, Osaka Y, Kuriyama R, Abe T, Takeuchi J.
    Clin Nephrol; 1979 Dec 20; 12(6):248-53. PubMed ID: 527278
    [Abstract] [Full Text] [Related]

  • 26. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP.
    N Z Med J; 1977 Oct 12; 86(597):332-4. PubMed ID: 272538
    [Abstract] [Full Text] [Related]

  • 27. A simple test for early detection of severe renal homograft rejection.
    Oppolzer R, Leithner C, Wolf A, Pinggera W, Stummvoll H.
    Proc Eur Dial Transplant Assoc; 1975 Oct 12; 11():326-32. PubMed ID: 667
    [Abstract] [Full Text] [Related]

  • 28. [Excretion of the fibrin-fibrinogen degradation products as a sign of rejection of transplanted kidney].
    Belitskaia GA, Ena IaM, Drannik GN, Varetskaia TV, Tsynkalovskaia SN.
    Urol Nefrol (Mosk); 1976 Oct 12; (5):52-5. PubMed ID: 793136
    [No Abstract] [Full Text] [Related]

  • 29. [Fibrin degradation products (FDP) in the urine after kidney transplantation].
    Malý J, Pecka M, Erben J, Radochová D, Bláha M, Vanásek J, Siroký O, Zahradník J.
    Vnitr Lek; 1983 Jul 12; 29(6):598-603. PubMed ID: 6351421
    [No Abstract] [Full Text] [Related]

  • 30. Urinary excretion of NAG and FDP in acute renal graft rejection.
    Garcia B, Thompson AE, Tucker SM, Wing AJ.
    Proc Eur Dial Transplant Assoc; 1975 Jul 12; 11():311-9. PubMed ID: 1105552
    [Abstract] [Full Text] [Related]

  • 31. [Role of IL-8 and defensins in pathogenesis of chronic glomerulonephritis and pyelonephritis].
    Rebenok AZh, Tikhonov II, Chizh AS.
    Ter Arkh; 1999 Jul 12; 71(8):62-7. PubMed ID: 10515041
    [Abstract] [Full Text] [Related]

  • 32. Urinary excretion of factor-VIII-related antigen and fibrin(ogen) degradation fragments D and E after kidney transplantation.
    Ponticelli C, Ruggeri ZM, Gordon YB, Ardaillou N, Larrieu MJ, Tarantino A, Coppola R, Mannucci PM.
    Transplant Proc; 1979 Mar 12; 11(1):448-51. PubMed ID: 377673
    [No Abstract] [Full Text] [Related]

  • 33. [Kidney transplant rejection and the original kidney disease of the recipient].
    Nizze H, Brockmöller S.
    Verh Dtsch Ges Pathol; 1989 Mar 12; 73():233-7. PubMed ID: 2482607
    [Abstract] [Full Text] [Related]

  • 34. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K, Matsunaga T, Kawahara S, Sakamoto S, Kamitsuji H.
    Thromb Res; 1989 Feb 15; 53(4):367-77. PubMed ID: 2929008
    [Abstract] [Full Text] [Related]

  • 35. [Inhibition of leukocyte migration, complement fixing antibodies and fibrinogen fibrin split products in the urine of patients after cadaver kidney transplantation].
    Drannik GN, Baran EIa.
    Urol Nefrol (Mosk); 1978 Feb 15; (3):18-21. PubMed ID: 351908
    [No Abstract] [Full Text] [Related]

  • 36. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
    Michielsen P, Roels L, Vanrenterghem Y, Boel A, van Damme B, Vermylen J.
    Clin Nephrol; 1976 Mar 15; 5(3):105-13. PubMed ID: 1261101
    [Abstract] [Full Text] [Related]

  • 37. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
    Miyamura S.
    Nihon Jinzo Gakkai Shi; 1978 Jan 15; 20(1):67-78. PubMed ID: 650992
    [No Abstract] [Full Text] [Related]

  • 38. [Fibrin (ogen) Split products of nephropathies].
    Anger H.
    Urologe A; 1975 Jan 15; 14(1):20-4. PubMed ID: 234643
    [Abstract] [Full Text] [Related]

  • 39. The role of hemocoagulation in acute clinical rejection of kidney allograft. Clinical and therapeutical investigations in 48 patients.
    Cortellaro M, Pogliani E, Rossi E, Maioli M, Ponticelli C, Vallino F, Politi A, Polli EE.
    Haematologica; 1975 Dec 15; 60(4):446-65. PubMed ID: 816715
    [No Abstract] [Full Text] [Related]

  • 40. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
    Astrug A, Shipkova P.
    Vutr Boles; 1982 Dec 15; 21(5):81-8. PubMed ID: 7164412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.